Sequana Medical has leveraged its alfapump® experience and is developing alfapump® DSR, a fully implanted system for DSR therapy in patients with volume overload due to heart failure.
alfapump® DSR combines three proven elements:
The sodium-free infusate is administered to the peritoneal cavity via the surgically implanted port, which allows for flexible dosing to remove the desired amount of sodium. The DSR infusate remains there for a pre-determined period of time before the DSR infusate and the extracted sodium is pumped to the bladder and eliminated through urination.
Preparations are underway for a repeated dose alfapump® DSR study to commence in H2 2019.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.